Resiliva 80mg Tablet – Comprehensive Product Description

Resiliva 80mg Tablet is a prescription medication containing Resmetirom, a selective thyroid hormone receptor-β (THR-β) agonist. It is primarily used for the treatment of adults diagnosed with noncirrhotic nonalcoholic steatohepatitis (NASH) accompanied by moderate to advanced liver fibrosis.

🩺 Therapeutic Indications

Resiliva 80mg is indicated for:

• Noncirrhotic Nonalcoholic Steatohepatitis (NASH): To improve liver fibrosis and resolve NASH without worsening of fibrosis.

⚙️ Mechanism of Action

Resmetirom, the active ingredient in Resiliva, selectively activates thyroid hormone receptor-β in the liver, leading to increased hepatic fat metabolism. This action reduces hepatic fat accumulation, inflammation, and fibrosis, thereby improving liver histology in NASH patients.

💊 Dosage & Administration

Recommended Dosage:

• Patients weighing less than 100 kg: 80 mg orally once daily.
• Patients weighing 100 kg or more: 100 mg orally once daily.

Administration Guidelines:

• Take Resiliva orally once daily, with or without food, as directed by your healthcare provider.

⚠️ Warnings & Precautions

• Monitoring: Regular monitoring of liver function tests is recommended during treatment.
• Pregnancy & Lactation: The safety of Resiliva during pregnancy and breastfeeding has not been established. Consult your healthcare provider before use.
• Drug Interactions: Inform your doctor about all medications you are taking, as Resiliva may interact with other drugs.

🚫 Contraindications

• Known hypersensitivity to Resmetirom or any component of the formulation.

🤒 Common Side Effects

• Diarrhea
• Nausea
• Vomiting
• Itching
• Dizziness

If any of these side effects persist or worsen, contact your healthcare provider promptly.

📦 Storage

• Store at room temperature, below 30°C.
• Keep the medication in its original packaging to protect from moisture and light.
• Keep out of reach of children.

🏭 Manufacturer

Everest Pharmaceuticals Ltd.

📌 Note

Resiliva 80mg Tablet should be used under the supervision of a qualified healthcare professional. Regular monitoring of liver function tests is essential during treatment.